T. D. de Reijke

T. D. de Reijke, J. J. de la Rosette, E. Liem, 2016, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Reduction of unnecessary use of indwelling urinary catheters

T. D. de Reijke, B. Buurman, S. Geerlings, 2013, BMJ quality & safety.

Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis - mass spectrometry.

T. D. de Reijke, J. Nouta, M. Wuhrer, 2021, Journal of proteomics.

Recent advances in extracellular vesicle research for urological cancers: From technology to application.

K. Pienta, T. D. de Reijke, Yanqing Wang, 2019, Biochimica et biophysica acta. Reviews on cancer.

Optical diagnostics for upper urinary tract urothelial cancer: technology, thresholds, and clinical applications.

D. D. de Bruin, T. D. de Reijke, T. V. van Leeuwen, 2015, Journal of endourology.

Detection of clinically significant prostate cancer in biopsy‐naïve men: direct comparison of systematic biopsy, multiparametric MRI‐ and contrast‐ultrasound‐dispersion imaging‐targeted biopsy

C. D. Savci-Heijink, T. D. de Reijke, M. Mischi, 2020, BJU international.

Urinary Cytokines Reflecting the Immunological Response in the Urinary Bladder to Biological Response Modifiers: Their Practical Use

T. D. de Reijke, K. Kurth, D. Schamhart, 2000, European Urology.

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.

T. D. de Reijke, N. Lawrentschuk, P. Stricker, 2022, European urology focus.

Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified Approach.

T. D. de Reijke, E. Basch, T. Steuber, 2015, European urology.

Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer

T. D. de Reijke, K. Aben, V. Kataja, 2018, BJU international.

Second-line therapy in patients with metastatic castration-resistant prostate cancer with progression after or under docetaxel: A systematic review of nine randomized controlled trials.

T. D. de Reijke, R. Vernooij, R. V. van Moorselaar, 2017, Seminars in oncology.

Tissue polypeptide-specific antigen (TPS) determinations before and during intermittent maximal androgen blockade in patients with metastatic prostatic carcinoma.

L. Collette, T. D. de Reijke, U. Studer, 2003, European urology.

Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women.

T. D. de Reijke, G. ter Riet, S. Geerlings, 2012, Archives of internal medicine.

Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.

D. D. de Bruin, T. D. de Reijke, J. J. de la Rosette, 2017, Diagnostic and interventional radiology.

The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol

D. D. de Bruin, T. D. de Reijke, J. J. de la Rosette, 2014, BMJ Open.

Orchiectomy and orchiectomy plus mitomycin C for metastatic prostate cancer in patients with poor prognosis: the final results of a European Organization for Research in Cancer Therapy Genitourinary Group Trial.

T. D. de Reijke, R. Sylvester, J. Kliment, 1999, The Journal of urology.

Routine urinalysis in patients with a blunt abdominal trauma mechanism is not valuable to detect urogenital injury

T. D. de Reijke, C. H. van der Vlies, J. Goslings, 2013, Emergency Medicine Journal.

External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome.

T. D. de Reijke, A. Haese*, M. Graefen, 2010, European urology.

Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891.

L. Collette, T. D. de Reijke, U. Studer, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does post-operative radiotherapy (P-RXT) after radical prostatectomy (Px) improve progression-free survival (PFS) in pT3N0 prostate cancer (PC)? (EORTC 22911).

L. Collette, T. D. de Reijke, P. Rigatti, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

T. D. de Reijke, A. Horwich, C. Parker, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

First‐line non‐cytotoxic therapy in chemotherapy‐naive patients with metastatic castration‐resistant prostate cancer: a systematic review of 10 randomised clinical trials

T. D. de Reijke, R. Vernooij, R. V. van Moorselaar, 2017, BJU international.

Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.

S. Fosså, T. D. de Reijke, B. Tombal, 2014, European journal of cancer.

Is age a prognostic factor for treatment outcome in renal cell cancer-A comprehensive review.

T. D. de Reijke, J. Rioja, J. J. de la Rosette, 2009, Critical reviews in oncology/hematology.

Re: Ten-year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.

T. D. de Reijke, J. Van Moorselaar, 2017, European urology.

The efficacy of Apaziquone in the treatment of bladder cancer

T. D. de Reijke, Francisco Caramés Masana, 2017, Expert opinion on pharmacotherapy.

Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study

P. R. Bloemen, D. D. de Bruin, T. D. de Reijke, 2020, JMIR research protocols.

Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study (Preprint)

P. R. Bloemen, D. D. de Bruin, T. D. de Reijke, 2019 .

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project

T. D. de Reijke, S. Crouzet, A. Villers, 2016, World Journal of Urology.

Image-guided in-Vivo Needle-Based Confocal Laser Endomicroscopy in the Prostate: Safety and Feasibility Study in 2 Patients

D. D. de Bruin, T. D. de Reijke, C. Mannaerts, 2022, Technology in cancer research & treatment.

Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project

D. D. de Bruin, T. D. de Reijke, A. Villers, 2016, World Journal of Urology.

Best practice in the treatment of nonmuscle invasive bladder cancer

T. D. de Reijke, A. Anastasiadis, 2012, Therapeutic advances in urology.

Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging

T. D. de Reijke, T. V. van Leeuwen, R. Nieuwland, 2020, PloS one.

Appropriate antibiotic use for patients with complicated urinary tract infections in 38 Dutch Hospital Departments: a retrospective study of variation and determinants

T. D. de Reijke, R. Geskus, S. Geerlings, 2015, BMC Infectious Diseases.

Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer—A Review

T. D. de Reijke, M. Hulshof, J. Oddens, 2021, Cancers.

Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer

T. D. de Reijke, J. Schellens, J. Beijnen, 2005, Clinical Cancer Research.

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.

W. Oyen, T. H. van der Kwast, M. Babjuk, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Een onbekende procedure: double-barreled wet colostomy

T. D. de Reijke, H. Beerlage, J. Oddens, 2020, Tijdschrift voor Urologie.

Nationwide treatment patterns and survival of older patients with prostate cancer.

T. D. de Reijke, K. Aben, R. Vernooij, 2019, Journal of geriatric oncology.

The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.

T. D. de Reijke, J. Witjes, R. Sylvester, 2014, European urology.

Phase 2 study of adjuvant intravesical instillations of apaziquone for high risk nonmuscle invasive bladder cancer.

T. D. de Reijke, J. Witjes, T. Reijke, 2012, The Journal of urology.

Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995–2005: an analysis of PALGA, the Dutch national histopathology registry

A. Zwinderman, T. D. de Reijke, E. Cauberg, 2010, BJU international.

Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer

T. D. de Reijke, J. Witjes, H. Vergunst, 2009, World Journal of Urology.

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies

T. D. de Reijke, A. Postema, J. Oddens, 2022, Therapeutic advances in urology.

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).

Christopher U. Jones, A. Kishan, M. Sydes, 2022, European urology.

Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study.

L. Collette, T. D. de Reijke, U. Studer, 2003, European urology.

Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy

T. D. de Reijke, G. Sanders, J. P. Straalen, 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Prostate specific antigen: a prognostic marker of survival in good prognosis metastatic prostate cancer? (EORTC 30892).

L. Collette, T. D. de Reijke, F. Schröder, 2003, European urology.

Insight into bladder cancer care: study protocol of a large nationwide prospective cohort study (BlaZIB)

L. Kiemeney, T. D. de Reijke, K. Aben, 2020, BMC Cancer.

Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis

A. Kishan, L. Collette, T. D. de Reijke, 2019, JAMA oncology.

Adjuvant hormone therapy in locally advanced and localized prostate cancer: three EORTC trials.

L. Collette, T. D. de Reijke, M. Bolla, 2002, Frontiers of radiation therapy and oncology.

Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials

Jonathan E. Shoag, A. Kishan, M. Sydes, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Local tract metastasis of prostatic adenocarcinoma 8 years after (125)iodine brachytherapy.

T. D. de Reijke, L. Blank, W. Wiersinga, 2001, The Journal of urology.

A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer

T. D. de Reijke, J. Crezee, H. Rodermond, 2022, Scientific Reports.

Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.

T. D. de Reijke, K. Kurth, D. Schamhart, 1996, The Journal of urology.

Prognostic factors and percutaneous nephrolithotomy morbidity: a multivariate analysis of a contemporary series using the Clavien classification.

T. D. de Reijke, M. P. Laguna, P. Tsakiris, 2008, The Journal of urology.

Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study

C. D. Savci-Heijink, T. D. de Reijke, E. Liem, 2018, Medical Oncology.

Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature

T. D. de Reijke, T. Reijke, J. Rosette, 2011, Indian journal of urology : IJU : journal of the Urological Society of India.

The effects of intravesical pretreatment with pentosan polysulfate on the bacillus Calmette-Guérin induced immune reaction of the guinea pig.

T. D. de Reijke, K. Kurth, D. Schamhart, 1994, The Journal of urology.

The Role of Fluorescence in Situ Hybridization for Predicting Recurrence after Adjuvant Bacillus Calmette-Guérin in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer Patients: A Systematic Review and Meta-Analysis of Individual Patient Data.

T. D. de Reijke, L. Bubendorf, C. Dinney, 2020, The Journal of urology.

BCG dose reduction by decreasing the instillation frequency: effects on local Th1/Th2 cytokine responses in a mouse model.

T. D. de Reijke, K. Kurth, D. Schamhart, 2005, European urology.

The Current State of Predicting Response on Bacillus Calmette-Guérin Treatment for Nonmuscle Invasive Bladder Cancer is Not Yet Useful for Patients but Attributes to Understanding Its Mechanisms of Action.

T. D. de Reijke, J. Oddens, 2017, European urology.

Strontium(89) chloride versus palliative local field radiotherapy in patients with hormonal escaped prostate cancer: a phase III study of the European Organisation for Research and Treatment of Cancer, Genitourinary Group.

L. Collette, T. D. de Reijke, M. Debois, 2003, European urology.

Immunostimulation in the urinary bladder by local application of Nocardia rubra cell-wall skeletons (Rubratin) and bacillus Calmette-Guérin as therapy for superficial bladder cancer: a comparative study.

T. D. de Reijke, K. Kurth, E. C. Boer, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice

T. D. de Reijke, J. Boormans, E. Schaake, 2022, European urology open science.

Management of blunt renal injury in a level 1 trauma centre in view of the European guidelines.

T. D. de Reijke, O. V. van Delden, C. H. van der Vlies, 2012, Injury.

New developments in castrate‐resistant prostate cancer

T. D. de Reijke, M. Mason, T. D. Reijke, 2012, BJU international.

Duration of androgen suppression in the treatment of prostate cancer.

M. Piérart, L. Collette, T. D. de Reijke, 2009, The New England journal of medicine.

Propagation of human spermatogonial stem cells in vitro.

Theo M de Reijke, Sjoerd Repping, T. D. de Reijke, 2009, JAMA.

Complications of prostate biopsy

Anastasios Anastasiadis, Georgios Dimitriadis, T. D. de Reijke, 2013, Expert review of anticancer therapy.

Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891).

L. Collette, T. D. de Reijke, U. Studer, 2008, European urology.

Urinary interleukin-2 monitoring during prolonged bacillus Calmette-Guerin treatment: can it predict the optimal number of instillations?

T. D. de Reijke, K. Kurth, D. Schamhart, 1999, The Journal of urology.

Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladd

T. D. de Reijke, T. Gorlia, R. Sylvester, 2010, European urology.

Emerging intravesical drugs for the treatment of non muscle-invasive bladder cancer

T. D. de Reijke, J. Crijnen, 2018, Expert opinion on emerging drugs.

Laser treatment of the prostate using the Urolase fiber: the Dutch experience.

T. D. de Reijke, J. Mooibroek, J. J. de la Rosette, 1996, The Journal of urology.

Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies

K. Pienta, T. D. de Reijke, J. J. de la Rosette, 2018, Nature Reviews Urology.

Incidental carcinoma of the prostate.

T. D. de Reijke, K. Kurth, G. van Andel, 1995, Seminars in surgical oncology.

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

H. G. van der Poel, T. D. de Reijke, J. Witjes, 1998, Urology.

Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group.

L. Collette, S. Fosså, T. D. de Reijke, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer, fatigue and the return of patients to work-a prospective cohort study.

T. D. de Reijke, M. Sprangers, J. de Haes, 2003, European journal of cancer.

Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer

T. D. de Reijke, J. Schalken, H. Vergunst, 2015, Clinical Cancer Research.

Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.

T. D. de Reijke, J. Schalken, H. Vergunst, 2014, European urology.

Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911).

M. Piérart, L. Collette, T. D. de Reijke, 2005, European journal of cancer.

Embryonic stem cell-like cells derived from adult human testis.

T. D. de Reijke, Á. Raya, H. L. Roepers-Gajadien, 2010, Human reproduction.

Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.

Geert Trooskens, Wim Van Criekinge, Theo M de Reijke, 2016, European urology.

Prostate cancer biomarker profiles in urinary sediments and exosomes.

T. D. de Reijke, J. Schalken, P. Mulders, 2014, The Journal of urology.

Non-invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles

T. Wurdinger, T. D. de Reijke, A. Geldof, 2016, Oncotarget.

Metastatic prostate cancer remains incurable, why?

K. Pienta, T. D. de Reijke, W. Xue, 2018, Asian journal of urology.

Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions.

T. D. de Reijke, A. Haese*, M. Graefen, 2011, The Journal of urology.

Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro

K. Pienta, T. D. de Reijke, L. Vermeulen, 2021, Medical Oncology.

Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium

K. Pienta, T. D. de Reijke, Yoon‐Kyoung Cho, 2020, Journal of extracellular vesicles.

Extracellular vesicle isolation from human renal cancer tissue

K. Pienta, T. D. de Reijke, P. Pierorazio, 2020, Medical Oncology.

The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients

C. D. Savci-Heijink, D. D. de Bruin, T. D. de Reijke, 2015, World Journal of Urology.

Current position of diagnostics and surgical treatment for upper tract urothelial carcinoma.

D. D. de Bruin, T. D. de Reijke, T. V. van Leeuwen, 2017, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer

Theo M de Reijke, T. D. de Reijke, S. Langbein, 2007, Expert review of molecular diagnostics.

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.

A. Kishan, T. D. de Reijke, H. Sandler, 2022, The Lancet. Oncology.

Long-term efficacy and safety of nilutamide plus castration in advanced prostate cancer, and the significance of early prostate specific antigen normalization. International Anandron Study Group.

T. D. de Reijke, F. Debruyne, R. Janknegt, 1997, The Journal of urology.

Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.

L. Collette, T. D. de Reijke, U. Studer, 2014, European urology.

A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.

L. Potters, T. D. de Reijke, J. Kleijnen, 2015, European journal of cancer.

Prostate cancer: ESMO Consensus Conference Guidelines 2012.

T. D. de Reijke, D. Dearnaley, A. Horwich, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Considerations Regarding Prostate Biopsies

T. D. de Reijke, H. Beerlage, J. J. de la Rosette, 1998, European Urology.

How to improve the effectiveness of transurethral resection in nonmuscle invasive bladder cancer?

Theo M de Reijke, T. D. de Reijke, E. Cauberg, 2009, Current opinion in urology.

Improving postoperative radiotherapy following radical prostatectomy

T. D. de Reijke, B. Pieters, D. Lipman, 2017, Expert review of anticancer therapy.

Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading.

C. D. Savci-Heijink, D. D. de Bruin, T. D. de Reijke, 2020, European urology focus.

Confocal Laser Endomicroscopy for the Diagnosis of Urothelial Carcinoma in the Bladder and the Upper Urinary Tract: Protocols for Two Prospective Explorative Studies

C. D. Savci-Heijink, D. D. de Bruin, T. D. de Reijke, 2018, JMIR research protocols.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees.

M. Babjuk, T. D. de Reijke, S. Culine, 2019, European urology.

Rectal squamous cell carcinoma 11 years after brachytherapy for carcinoma of the prostate.

T. D. de Reijke, L. Blank, E. A. Rauws, 2003, The Journal of urology.

Analogous detection of circulating tumor cells using the AccuCyte®—CyteFinder® system and ISET system in patients with locally advanced and metastatic prostate cancer

K. Pienta, L. Wood, T. D. de Reijke, 2018, The Prostate.

Work ability and return-to-work in cancer patients

T. D. de Reijke, M. Sprangers, F. van Dijk, 2008, British Journal of Cancer.

Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.

T. D. de Reijke, B. V. van Rhijn, A. Vis, 2023, Clinical genitourinary cancer.

Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study.

E. D. Geijsen, Johannes Crezee, Theo M de Reijke, 2015, The Journal of urology.

Polyomavirus BK in the pathogenesis of bladder cancer.

T. D. de Reijke, F. Bemelman, K. V. D. D. van Donselaar-van der Pant, 2013, The Netherlands journal of medicine.

The Successful Return-To-Work Questionnaire for Cancer Survivors (I-RTW_CS): Development, Validity and Reproducibility

M. Frings-Dresen, M. Kersten, T. D. de Reijke, 2020, The Patient - Patient-Centered Outcomes Research.

Optical Coherence Tomography as a Tool for In Vivo Staging and Grading of Upper Urinary Tract Urothelial Carcinoma: A Study of Diagnostic Accuracy.

T G van Leeuwen, D. D. de Bruin, T. D. de Reijke, 2016, The Journal of urology.

Volumetric in vivo visualization of upper urinary tract tumors using optical coherence tomography: a pilot study.

Ton G van Leeuwen, Berrend G Muller, Daniel M de Bruin, 2013, The Journal of urology.

Results of a phase 1 dose escalation study of intravesical TMX-101 in patients with nonmuscle invasive bladder cancer.

T. D. de Reijke, J. Witjes, H. Vergunst, 2013, The Journal of urology.

Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer.

T. D. de Reijke, M. Hulshof, J. Oddens, 2022, European urology.

Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.

C. D. Savci-Heijink, T. D. de Reijke, M. Roobol, 2018, European urology oncology.

The added value of systematic biopsy in men with suspicion of prostate cancer undergoing multiparametric MRI-targeted biopsy.

T. D. de Reijke, M. Gayet, H. Beerlage, 2019, Urologic oncology.

Ablation energies for focal treatment of prostate cancer

T. D. de Reijke, S. Crouzet, S. Eggener, 2018, World Journal of Urology.

Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial

D. D. de Bruin, T. D. de Reijke, J. J. de la Rosette, 2016, BMC Cancer.

Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol.

T. D. de Reijke, J. J. de la Rosette, H. Wijkstra, 2009, The Journal of urology.

Confocal Laser Endomicroscopy and Optical Coherence Tomography for the Diagnosis of Prostate Cancer: A Needle-Based, In Vivo Feasibility Study Protocol (IDEAL Phase 2A)

C. D. Savci-Heijink, D. D. de Bruin, T. D. de Reijke, 2018, JMIR research protocols.

Training in laparoscopic urology

Hessel Wijkstra, Jean de la Rosette, T. D. de Reijke, 2006, Current opinion in urology.

Mentor-initiated approach in laparoscopic radical prostatectomy.

T. D. de Reijke, R. Velthoven, J. J. de la Rosette, 2006, Journal of endourology.

Computed tomography-urography for upper urinary tract imaging: is it required for all patients who present with hematuria?

T. D. de Reijke, E. Cauberg, M. P. Laguna, 2011, Journal of endourology.

The additional value of blood cultures in patients with complicated urinary tract infections.

T. D. de Reijke, S. Geerlings, M. Hulscher, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study

François Tranquart, Martijn Smeenge, Hessel Wijkstra, 2017, Investigative radiology.

The Bard® BTA Test: Its Mode of Action, Sensitivity and Specificity, Compared to Cytology of Voided Urine, in the Diagnosis of Superficial Bladder Cancer

H. G. van der Poel, T. D. de Reijke, J. Witjes, 1998, European Urology.

Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS".

M. Babjuk, T. D. de Reijke, M. Wirth, 2020, European urology.

Current Status of Minimally Invasive Treatment Options for Localized Prostate Carcinoma

T. D. de Reijke, A. Zlotta, G. Aus, 2000, European Urology.

Brachytherapy with transperineal (125)Iodine seeds for localized prostate cancer.

T. D. de Reijke, L. Blank, D. González González, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance

Mesut Remzi, Markus Graefen, Alexander Haese, 2012, BJU international.

Ex-vivo study in nephroureterectomy specimens defining the role of 3-D upper urinary tract visualization using optical coherence tomography and endoluminal ultrasound

Marcel van Herk, Ton G van Leeuwen, Paul Cernohorsky, 2018, Journal of medical imaging.

Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer

C. D. Savci-Heijink, T. D. de Reijke, M. Pollak, 2019, BMC Cancer.

Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial

T. D. de Reijke, K. Aben, H. V. van Melick, 2018, Contemporary clinical trials communications.

Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer

T. D. de Reijke, P. Stricker, J. Oddens, 2022, BJU international.

Dynamic contrast‐enhanced ultrasound parametric imaging for the detection of prostate cancer

Martijn Smeenge, Hessel Wijkstra, T. D. de Reijke, 2016, BJU international.

Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892.

L. Collette, T. D. de Reijke, K. Kurth, 2004, European urology.

BioXmark® liquid fiducial markers for image guided radiotherapy in muscle invasive bladder cancer, a safety and performance trial.

T. D. de Reijke, M. Hulshof, K. Hinnen, 2020, The British journal of radiology.

Editorial comment on: Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.

T. D. de Reijke, 2009, European urology.

The First In Vivo Needle‐Based Optical Coherence Tomography in Human Prostate: A Safety and Feasibility Study

C. D. Savci-Heijink, D. D. de Bruin, T. D. de Reijke, 2019, Lasers in surgery and medicine.

Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

T. D. de Reijke, R. Sylvester, K. Kurth, 2005, The Journal of urology.

Standard approach and future perspective for the management of benign prostatic hyperplasia from a health-economics point of view: the role of transperineal laser ablation

T. D. de Reijke, V. Lorenzoni, G. Manenti, 2023, Frontiers in Urology.

Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study

P. R. Bloemen, D. D. de Bruin, T. D. de Reijke, 2020, JMIR research protocols.

Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response.

T. D. de Reijke, J. Witjes, H. Vergunst, 2006, The Journal of urology.

Novel multisensor probe for monitoring bladder temperature during locoregional chemohyperthermia for nonmuscle-invasive bladder cancer: technical feasibility study.

Hans Crezee, Jean de la Rosette, Theo M de Reijke, 2013, Journal of endourology.

Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies.

T. D. de Reijke, F. Jankevicius, D. Characiejus, 2013, Anticancer research.

Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.

A. Kishan, L. Collette, P. Boutros, 2019, European Urology.

The diagnostic yield and concordance of ureterorenoscopic biopsies for grading of upper tract urothelial carcinoma: a Dutch nationwide analysis.

T. D. de Reijke, R. Vernooij, J. Freund, 2020, Journal of endourology.

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer

T. D. de Reijke, J. Witjes, N. Aaronson, 2022, Health and Quality of Life Outcomes.

Monopolar vs. bipolar transurethral resection for non-muscle invasive bladder carcinoma: A post-hoc analysis from a randomized controlled trial.

T. D. de Reijke, J. J. de la Rosette, S. Naito, 2018, Urologic oncology.

Urothelial carcinoma in both adnexa following perforation during transurethral resection of a non-muscle-invasive bladder tumor: a case report and literature review

T. D. de Reijke, J. J. de la Rosette, A. Anastasiadis, 2012, Expert review of anticancer therapy.

Quantitative measurement of attenuation coefficients of bladder biopsies using optical coherence tomography for grading urothelial carcinoma of the bladder.

Ton G van Leeuwen, Mike Visser, Daniel M de Bruin, 2010, Journal of biomedical optics.

Vulvar and vaginal implantation of transitional cell carcinoma of the urinary tract.

T. D. de Reijke, J. G. van den Tweel, J. Noordzij, 1991, British journal of urology.

Analysis of biopsy findings and implant quality following ultrasonically-guided 125I implantation for localised prostatic carcinoma.

T. D. de Reijke, L. Blank, A. Hart, 1993, British journal of urology.

The Prostate Cancer gene 3 assay: indications for use in clinical practice

T. D. de Reijke, B. Tombal, A. De la taille, 2010, BJU international.

Transrectal Ultrasound in the Diagnosis of Prostate Cancer: State of the Art and Perspectives

Theo M. de Reijke, T. D. de Reijke, A. Hendrikx, 2001, European Urology.

Treatment of local progression following radiotherapy.

T. D. de Reijke, T. Wiegel, 2009, European journal of cancer.

A Cluster-Randomized Trial of Two Strategies to Improve Antibiotic Use for Patients with a Complicated Urinary Tract Infection

T. D. de Reijke, R. Geskus, S. Geerlings, 2015, PloS one.

The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis

T. D. de Reijke, R. Molenaar, J. Oddens, 2022, Bladder cancer.

Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences

R. E. Neal, D. D. de Bruin, T. D. de Reijke, 2019, Therapeutic advances in urology.

The feasibility and utility of cystoscopy-guided hydrogel marker placement in patients with muscle invasive bladder cancer.

T. D. de Reijke, G. van Andel, M. Hulshof, 2019, Practical radiation oncology.

Is focal therapy an alternative to active surveillance?

T. D. de Reijke, S. Gravas, 2010, Journal of endourology.

Development of late toxicity and International Prostate Symptom Score resolution after external-beam radiotherapy combined with pulsed dose rate brachytherapy for prostate cancer.

E. D. Geijsen, T. D. de Reijke, L. Blank, 2011, International journal of radiation oncology, biology, physics.

Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging

D. D. de Bruin, T. D. de Reijke, H. Beerlage, 2023, European urology open science.

Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.

T. D. de Reijke, J. Chin, E. Crawford, 2023, European urology.

Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer.

T. D. de Reijke, T. Wiegel, D. Bottke, 2009, European journal of cancer.

Kinetics of prostate-specific antigen after manipulation of the prostate.

T. D. de Reijke, K. Kurth, J. V. van Straalen, 1995, European journal of cancer.

Re: Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.

T. D. de Reijke, K. Kurth, D. Schamhart, 1998, The Journal of urology.

Long‐term complications of brachytherapy in local prostate cancer

T. D. de Reijke, M. Pilar Laguna, 2003, BJU international.

Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.

C. D. Savci-Heijink, T. D. de Reijke, J. J. de la Rosette, 2016, The Journal of urology.

MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy

C. D. Savci-Heijink, D. D. de Bruin, T. D. de Reijke, 2015, European Radiology.

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer

L. Kiemeney, T. D. de Reijke, K. Aben, 2023, World Journal of Urology.

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator

T. D. de Reijke, H. Beerlage, A. Postema, 2022, Therapeutic advances in urology.

An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen

T. D. de Reijke, J. Nouta, M. Wuhrer, 2018, Analytical chemistry.

Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study

D. D. de Bruin, T. D. de Reijke, J. Oddens, 2022, European urology open science.

Behavior of lipiodol markers during image guided radiotherapy of bladder cancer.

Arjan Bel, Marcel van Herk, Xiangfei Chai, 2010, International journal of radiation oncology, biology, physics.

[Pyelonephritis during pregnancy: a threat to mother and child].

T. D. de Reijke, O. V. van Delden, H. Wolf, 2007, Nederlandsch tijdschrift voor geneeskunde.

Whole bladder wall photodynamic therapy using 5-ALA: an experimental study in pigs

Martin J. C. van Gemert, Willem M. Star, Hugo J. van Staveren, 1996, European Conference on Biomedical Optics.

Comparison of Normal Piglet Bladder Damage after PDT with Oral or Intravesical Administration of ALA

H. J. van Staveren, T. D. de Reijke, W. Star, 2002, Lasers in Medical Science.

A surface tension magnetophoretic device for rare cell isolation and characterization

D. Stoianovici, K. Pienta, D. Petrisor, 2017, Medical Oncology.

íSPIES--a novel approach to advanced endoscopic imaging.

D. D. de Bruin, T. D. de Reijke, J. J. de la Rosette, 2014, Journal of endourology.

Improvements in endoscopic urothelial tumor visualization.

T. D. de Reijke, J. J. de la Rosette, G. Kamphuis, 2013, Journal of endourology.

Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate

T. D. de Reijke, E. Cauberg, C. Mamoulakis, 2011, World Journal of Urology.

Duration of androgen suppression in the treatment of prostate cancer.

M. Piérart, L. Collette, T. D. de Reijke, 2009, The New England journal of medicine.

Long-term efficacy and safety of nilutamide plus castration in advanced prostate cancer, and the significance of early prostate specific antigen normalization

T. D. de Reijke, T. Reijke, F. Debruyne, 1997 .

Treatment of local progression following radiotherapy.

T. D. de Reijke, T. Wiegel, 2009, European journal of cancer.

Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies.

T. D. de Reijke, F. Jankevicius, D. Characiejus, 2013, Anticancer research.

Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.

D. D. de Bruin, T. D. de Reijke, H. Wijkstra, 2017, Diagnostic and interventional radiology.

Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography

Ton G van Leeuwen, Jean de la Rosette, Berrend G Muller, 2015, Journal of medical imaging.

Novel minimally invasive treatments for lower urinary tract symptoms: a systematic review and network meta-analysis

D. D. de Bruin, T. D. de Reijke, J. Oddens, 2023, International braz j urol : official journal of the Brazilian Society of Urology.

Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.

T. D. de Reijke, P. Stricker, J. J. de la Rosette, 2017, European urology focus.

Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading.

C. D. Savci-Heijink, D. D. de Bruin, T. D. de Reijke, 2020, European urology focus.

Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants.

Bradley R Pieters, Theo M de Reijke, T. D. de Reijke, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.